https://www.selleckchem.com/pr....oducts/pamapimod-r-1
We read with great interest the paper by Goel et al about cardiovascular disease in Takayasu arteritis (TAK) (1). They conducted an open retrospective matched cohort study to estimate risk of comorbidities in TAK. They then find out that Cardiovascular morbidity was increased among patients with TAK. It had excellent study questions and very innovative ideas. However, a few matters need to be addressed.Supplemental oxygen and mechanical ventilation commonly used in premature infants may lead to chronic lung disease of